Louisiana 2021 Regular Session

Louisiana House Bill HCR50

Introduced
4/27/21  
Introduced
4/27/21  
Engrossed
4/27/21  
Engrossed
4/27/21  
Passed
5/3/21  

Caption

Designates May 2-9, 2021, as Tardive Dyskinesia Awareness Week

Impact

As a resolution rather than a legislative bill, HCR50 does not impose new laws or regulations. Instead, it serves as a public declaration aimed at fostering understanding and support for individuals living with TD. By designating an awareness week, the legislative body aims to engage the public and healthcare communities in discussions about the disorder, its symptoms, and the importance of proper treatment protocols. This could lead to improved screening and better care practices in the state, enhancing the quality of life for those affected by TD.

Summary

House Concurrent Resolution 50 (HCR50) designates May 2-9, 2021, as Tardive Dyskinesia Awareness Week in Louisiana. The resolution seeks to raise awareness about Tardive Dyskinesia (TD) — a movement disorder that can occur in individuals being treated with dopamine receptor blocking agents (DRBAs), such as certain antipsychotic medications. The resolution highlights the challenges faced by those with TD, including potential misdiagnosis and the critical need for regular screening as recommended by the American Psychiatric Association.

Sentiment

The sentiment surrounding HCR50 appears to be overwhelmingly positive, with bipartisan support reflected in the unanimous vote in the Senate (32 yeas, 0 nays). Legislators recognized the importance of raising public awareness about TD and its impact on individuals with chronic mental health conditions. The resolution creates an opportunity for constructive dialogue regarding mental health treatment and the side effects that some patients may experience, aligning with broader public health goals.

Contention

While there seems to be broad support for HCR50, potential contention might arise from differing perspectives on mental health treatment and medication side effects. Some stakeholders in the mental health community may argue for more robust legislative actions to ensure comprehensive care for individuals facing severe side effects from their medications. However, in this instance, HCR50 is a consensus-driven effort directed at awareness rather than a controversial legislative measure.

Companion Bills

No companion bills found.

Previously Filed As

LA HR86

Designates May 1-7, 2022, as Tardive Dyskinesia Awareness Week

LA HR113

Designates May 1-7, 2023, as Tardive Dyskinesia Awareness Week

LA SR0043

A resolution to designate May 1-6, 2023, as Tardive Dyskinesia Awareness Week.

LA SJR110

Designates first full week of May of each year as "Tardive Dyskinesia Awareness Week" in NJ.

LA SR20

Relative to Tardive Dyskinesia Awareness Week.

LA AJR120

Designates first full week of May of each year as "Tardive Dyskinesia Awareness Week" in NJ.

LA HR367

Designating the week of May 1, 2023, through May 7, 2023, as "Tardive Dyskinesia Awareness Week".

LA AJR234

Designates first full week of May of each year as "Tardive Dyskinesia Awareness Week" in NJ.

LA SR706

Designates the week of May 1, 2022, as "Tardive Dyskinesia Awareness Week" in Missouri

LA SR109

Designating the week of May 1 through 7, 2023, as "Tardive Dyskinesia Awareness Week" in Pennsylvania.

Similar Bills

No similar bills found.